In short
The 2026 China TIPS guideline (cirrhosis portal hypertension) makes TIPS first-line for preventing recurrent variceal bleeding and treating refractory ascites, standardizes covered-stent use, and details hepatic encephalopathy risk management via MDT.
What this guide covers: What is TIPS? · Main indications · Technique and stents · Managing complications · For patients
What is TIPS?
Transjugular Intrahepatic Portosystemic Shunt (TIPS) is a minimally invasive procedure that creates a channel inside the liver between the portal and hepatic veins, lowering portal pressure. It is done via a neck vein under image guidance.
Main indications
TIPS is first-line for preventing recurrent esophageal/gastric variceal bleeding after failure of drug-plus-endoscopy, and for refractory ascites unresponsive to diuretics. It is also a rescue for acute variceal hemorrhage and some hepatic hydrothorax or syndrome cases.
Technique and stents
Covered (PTFE) stents are standard, improving long-term patency (1-year ~85–90%). Target pressure drop is HVPG <12 mmHg or ≥30% reduction.
Managing complications
Hepatic encephalopathy (20–40%) is the main trade-off; lactulose/rifaximin and protein management mitigate it. A multidisciplinary team oversees selection, procedure, and follow-up.
For patients
TIPS can stop recurrent bleeding or remove resistant ascites, but it may cause confusion (encephalopathy). Discuss the balance of benefits and risks with your liver team.
Sources and further reading
One reference to a U.S. government health source (National Institutes of Health or MedlinePlus) for the medical background of this guide. It is context, not a substitute for advice from your treating doctor.
General information for international patients, not medical advice or a diagnosis. Read the medical disclaimer.


